Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.
Jennifer N. Goldstein, MD, MSc
Advertisement
Articles by Jennifer N. Goldstein, MD, MSc
A care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.
Advertisement
Latest Updated Articles
- Low-Cost Insulin for Socially At-Risk Patients: Evidence for Effectiveness
Published: June 11th 2021 | Updated:
- Impact of Care Coordination Based on Insurance and Zip Code
Published: May 31st 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Medicaid Work Requirements Set to Leave Millions Without Insurance
2
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
3
AMCP Nexus 2025: Advancing Health Policy and Patient Outcomes Together
4
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
5
